Crossmark

Marine Compound-Carpatamide D as a Potential Inhibitor Against TOP2A and Its Mutant D1021Y in Colorectal Cancer: Insights from DFT, MEP and Molecular Dynamics Simulation

Crossref DOI link: https://doi.org/10.1007/s12033-024-01265-9

Published Online: 2024-09-12

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Priyamvada, P.

Ashok, Gayathri

Mathpal, Shalini

Anbarasu, Anand

Ramaiah, Sudha https://orcid.org/0000-0002-4800-329X
Funding

Funding for this research was provided by:

Indian Council of Medical Research (IRIS ID: 2021-11889)
License Information

Text and Data Mining valid from 2024-09-12

Version of Record valid from 2024-09-12
More Information

Article History

Received: 9 July 2024

Accepted: 13 August 2024

First Online: 12 September 2024

Declarations

:

: The authors declare that they have no competing financial interests or personal relationships that could influence the work reported.

Document is current

Any future updates will be listed below